Up a level |
Szijgyarto, Zsolt, Flach, Koen D, Opdam, Mark, Palmieri, Carlo ORCID: 0000-0001-9496-2718, Linn, Sabine C, Wesseling, Jelle, Ali, Simak, Bliss, Judith M, Cheang, Maggie Chon U, Zwart, Wilbert et al (show 1 more authors)
(2019)
Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIES.
BREAST CANCER RESEARCH AND TREATMENT, 175 (1).
pp. 149-163.
Hickey, Theresa E, Selth, Luke A, Chia, Kee Ming, Laven-Law, Geraldine, Milioli, Heloisa H, Roden, Daniel, Jindal, Shalini, Hui, Mun, Finlay-Schultz, Jessica, Ebrahimie, Esmaeil et al (show 14 more authors)
(2021)
The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer.
NATURE MEDICINE, 27 (2).
310-+.